Baxter
BAX
#1063
Rank
$17.35 B
Marketcap
$34.06
Share price
0.96%
Change (1 day)
-24.92%
Change (1 year)

Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.

Operating Margin for Baxter (BAX)

Operating Margin as of June 2024 (TTM): -19.01%

According to Baxter's latest financial reports and stock price the company's current Operating Margin is -19.01%. At the end of 2022 the company had an Operating Margin of -12.96%.

Operating Margin history for Baxter from 2001 to 2023

Operating Margin at the end of each year

Year Operating Margin Change
2022-12.96%-199.24%
202113.06%6.87%
202012.22%28.4%
20199.51%-39.09%
201815.62%26.7%
201712.33%-75.04%
201649.39%788.75%
20155.56%-64.14%
201415.50%-11.65%
201317.54%-16.35%
201220.97%1.77%
201120.61%33.87%
201015.39%-31.72%
200922.54%8.57%
200820.76%4.5%
200719.87%12.01%
200617.74%14.19%
200515.53%28.56%
200412.08%-33.33%
200318.12%-14.98%
200221.32%9.42%
200119.48%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
17.17%-190.32%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
14.17%-174.54%๐Ÿ‡บ๐Ÿ‡ธ USA
9.46%-149.76%๐Ÿ‡บ๐Ÿ‡ธ USA
11.27%-159.28%๐Ÿ‡บ๐Ÿ‡ธ USA
16.21%-185.27%๐Ÿ‡บ๐Ÿ‡ธ USA
-0.42%-97.79%๐Ÿ‡บ๐Ÿ‡ธ USA
-5.01%-73.65%๐Ÿ‡บ๐Ÿ‡ธ USA
37.47%-297.11%๐Ÿ‡บ๐Ÿ‡ธ USA
2.82%-114.83%๐Ÿ‡บ๐Ÿ‡ธ USA
0.69%-103.63%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.